NO932867L - Vandige dispersjoner av zein og faste preparater med regulert frigjoerelse og med belegg avledet fra dispersjonene - Google Patents

Vandige dispersjoner av zein og faste preparater med regulert frigjoerelse og med belegg avledet fra dispersjonene

Info

Publication number
NO932867L
NO932867L NO932867A NO932867A NO932867L NO 932867 L NO932867 L NO 932867L NO 932867 A NO932867 A NO 932867A NO 932867 A NO932867 A NO 932867A NO 932867 L NO932867 L NO 932867L
Authority
NO
Norway
Prior art keywords
dispersions
zein
controlled release
solid preparations
release solid
Prior art date
Application number
NO932867A
Other languages
English (en)
Norwegian (no)
Other versions
NO932867D0 (no
Inventor
Benjamin Oshlack
Mark Chasin
James Mcginity
Roland Bodmeier
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Publication of NO932867D0 publication Critical patent/NO932867D0/no
Publication of NO932867L publication Critical patent/NO932867L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
    • C08J3/07—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media from polymer solutions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/14—Vegetable proteins
    • A23J3/18—Vegetable proteins from wheat
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P20/00—Coating of foodstuffs; Coatings therefor; Making laminated, multi-layered, stuffed or hollow foodstuffs
    • A23P20/10—Coating with edible coatings, e.g. with oils or fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2873—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5052—Proteins, e.g. albumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L89/00—Compositions of proteins; Compositions of derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D189/00—Coating compositions based on proteins; Coating compositions based on derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2389/00—Characterised by the use of proteins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nutrition Science (AREA)
  • Dispersion Chemistry (AREA)
  • Materials Engineering (AREA)
  • Wood Science & Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Peptides Or Proteins (AREA)
  • Paints Or Removers (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Confectionery (AREA)
NO932867A 1992-08-13 1993-08-12 Vandige dispersjoner av zein og faste preparater med regulert frigjoerelse og med belegg avledet fra dispersjonene NO932867L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/930,107 US5324351A (en) 1992-08-13 1992-08-13 Aqueous dispersions of zein and preparation thereof

Publications (2)

Publication Number Publication Date
NO932867D0 NO932867D0 (no) 1993-08-12
NO932867L true NO932867L (no) 1994-02-14

Family

ID=25458930

Family Applications (1)

Application Number Title Priority Date Filing Date
NO932867A NO932867L (no) 1992-08-13 1993-08-12 Vandige dispersjoner av zein og faste preparater med regulert frigjoerelse og med belegg avledet fra dispersjonene

Country Status (14)

Country Link
US (2) US5324351A (pt)
EP (1) EP0585688B1 (pt)
JP (1) JPH06172398A (pt)
KR (1) KR940005265A (pt)
CN (1) CN1086144A (pt)
AT (1) ATE172224T1 (pt)
AU (1) AU4462193A (pt)
CA (1) CA2103635A1 (pt)
DE (1) DE69321538T2 (pt)
IL (1) IL106647A0 (pt)
MX (1) MX9304900A (pt)
NO (1) NO932867L (pt)
PL (1) PL300087A1 (pt)
ZA (1) ZA935869B (pt)

Families Citing this family (169)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5266331A (en) * 1991-11-27 1993-11-30 Euroceltique, S.A. Controlled release oxycodone compositions
US5679145A (en) 1992-08-11 1997-10-21 E. Khashoggi Industries Starch-based compositions having uniformly dispersed fibers used to manufacture high strength articles having a fiber-reinforced, starch-bound cellular matrix
US5709827A (en) 1992-08-11 1998-01-20 E. Khashoggi Industries Methods for manufacturing articles having a starch-bound cellular matrix
US5662731A (en) 1992-08-11 1997-09-02 E. Khashoggi Industries Compositions for manufacturing fiber-reinforced, starch-bound articles having a foamed cellular matrix
US5810961A (en) 1993-11-19 1998-09-22 E. Khashoggi Industries, Llc Methods for manufacturing molded sheets having a high starch content
US5716675A (en) 1992-11-25 1998-02-10 E. Khashoggi Industries Methods for treating the surface of starch-based articles with glycerin
US20080075781A1 (en) * 1992-11-25 2008-03-27 Purdue Pharma Lp Controlled release oxycodone compositions
US20070275062A1 (en) * 1993-06-18 2007-11-29 Benjamin Oshlack Controlled release oxycodone compositions
US5747416A (en) * 1993-07-08 1998-05-05 Mcardle; Blaise Herbicidal and insecticidal protein-polysaccharide delivery compositions and methods for controlling plant and insect populations
US5645880A (en) * 1993-07-08 1997-07-08 Mcardle; Blaise Protein-polysaccharide complex composition and method of use
AU7219094A (en) * 1993-07-14 1995-02-13 Opta Food Ingredients, Inc. Shellac dispersions and coatings, and method of making
US6726930B1 (en) * 1993-09-09 2004-04-27 Penwest Pharmaceuticals Co. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5662933A (en) * 1993-09-09 1997-09-02 Edward Mendell Co., Inc. Controlled release formulation (albuterol)
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5773025A (en) * 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
US6083586A (en) 1993-11-19 2000-07-04 E. Khashoggi Industries, Llc Sheets having a starch-based binding matrix
US5736209A (en) 1993-11-19 1998-04-07 E. Kashoggi, Industries, Llc Compositions having a high ungelatinized starch content and sheets molded therefrom
US6210714B1 (en) 1993-11-23 2001-04-03 Euro-Celtique S.A. Immediate release tablet cores of acetaminophen having sustained-release coating
US5500227A (en) * 1993-11-23 1996-03-19 Euro-Celtique, S.A. Immediate release tablet cores of insoluble drugs having sustained-release coating
US5843544A (en) 1994-02-07 1998-12-01 E. Khashoggi Industries Articles which include a hinged starch-bound cellular matrix
US5776388A (en) 1994-02-07 1998-07-07 E. Khashoggi Industries, Llc Methods for molding articles which include a hinged starch-bound cellular matrix
US5705203A (en) 1994-02-07 1998-01-06 E. Khashoggi Industries Systems for molding articles which include a hinged starch-bound cellular matrix
CA2145497A1 (en) * 1994-05-10 1995-11-11 Subramaniam Mahadevan Protected feed product
US5596080A (en) * 1994-10-03 1997-01-21 E. I. Du Pont De Nemours And Company Crosslinking processes/agents for zein
US5733575A (en) * 1994-10-07 1998-03-31 Bpsi Holdings, Inc. Enteric film coating compositions, method of coating therewith, and coated forms
US5736178A (en) * 1995-05-02 1998-04-07 Opta Food Ingredients, Inc. Colloidal dispersions of gluten, method of making and use therefor
US6197199B1 (en) 1995-09-05 2001-03-06 Mcardle Blaise Use of protein-polysaccharide complex in removal of contaminants
US5942123A (en) * 1995-09-05 1999-08-24 Mcardle; Blaise Method of using a filter aid protein-polysaccharide complex composition
US6168857B1 (en) 1996-04-09 2001-01-02 E. Khashoggi Industries, Llc Compositions and methods for manufacturing starch-based compositions
US5939356A (en) * 1996-06-21 1999-08-17 Southwest Research Institute Controlled release coated agricultural products
WO1998001117A1 (en) 1996-07-08 1998-01-15 Edward Mendell Co., Inc. Sustained release matrix for high-dose insoluble drugs
DE69708321D1 (de) * 1996-12-18 2001-12-20 Isocell Neuilly Sur Seine Biodegradierbare prolaminkapsel
US6020008A (en) * 1997-02-14 2000-02-01 Wm. Wrigley Jr. Company Prolamine miscible blends
US6056977A (en) * 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
US20060141036A1 (en) * 1997-12-12 2006-06-29 Andrx Labs Llc HMG-CoA reductase inhibitor extended release formulation
US20040029962A1 (en) * 1997-12-12 2004-02-12 Chih-Ming Chen HMG-COA reductase inhibitor extended release formulation
PT1685839E (pt) 1997-12-22 2013-07-08 Euro Celtique Sa Forma de dosagem farmacêutica por via oral compreendendo uma combinação de um agonista opióide e de um antagonista opióide
KR100417490B1 (ko) * 1997-12-22 2004-02-05 유로-셀티크 소시에떼 아노뉨 오피오이드 제형의 남용을 방지하는 방법
US6375957B1 (en) 1997-12-22 2002-04-23 Euro-Celtique, S.A. Opioid agonist/opioid antagonist/acetaminophen combinations
CA2326183A1 (en) * 1998-04-02 1999-10-14 Genencor International, Inc. Modified starch coating
US6524620B2 (en) 1998-07-20 2003-02-25 Andrx Pharmaceuticals, Inc. Diltiazem controlled release formulation and method of manufacture
US20040013613A1 (en) * 2001-05-18 2004-01-22 Jain Rajeev A Rapidly disintegrating solid oral dosage form
US8236352B2 (en) 1998-10-01 2012-08-07 Alkermes Pharma Ireland Limited Glipizide compositions
US20080213378A1 (en) * 1998-10-01 2008-09-04 Elan Pharma International, Ltd. Nanoparticulate statin formulations and novel statin combinations
US8293277B2 (en) * 1998-10-01 2012-10-23 Alkermes Pharma Ireland Limited Controlled-release nanoparticulate compositions
EP1117384A1 (en) * 1998-10-01 2001-07-25 Elan Pharma International Limited Controlled release nanoparticulate compositions
US20050048120A1 (en) * 1998-11-04 2005-03-03 Edgren David Emil Dosage form comprising self-destructive membrane
US6969529B2 (en) * 2000-09-21 2005-11-29 Elan Pharma International Ltd. Nanoparticulate compositions comprising copolymers of vinyl pyrrolidone and vinyl acetate as surface stabilizers
US6419960B1 (en) 1998-12-17 2002-07-16 Euro-Celtique S.A. Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
US6174559B1 (en) 1998-12-24 2001-01-16 Opta Food Ingredients, Inc. Gluten-derived colloidal dispersions and edible coatings therefrom and method of making
US6197353B1 (en) 1998-12-24 2001-03-06 Opta Food Ingredients, Inc. Gluten-derived colloidal dispersions, edible coatings therefrom and method of making
KR100330491B1 (ko) * 1999-03-12 2002-04-01 김성봉 자연분해가 가능한 방수코팅 용기의 제조방법
IL143375A0 (en) * 1999-09-30 2002-04-21 Penwest Pharmaceuticals Co Sustained release matrix systems for highly soluble drugs
US6395198B1 (en) 1999-10-01 2002-05-28 Mcardle Biaise Anti-caking and anti-dusting composition and corresponding methods
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
KR20130010512A (ko) 1999-10-29 2013-01-28 유로-셀티크 소시에떼 아노뉨 서방성 하이드로코돈 제형
US8771740B2 (en) * 1999-12-20 2014-07-08 Nicholas J. Kerkhof Process for producing nanoparticles by spray drying
ATE405264T1 (de) 2000-02-08 2008-09-15 Euro Celtique Sa Zusammensetzungen mit kontrollierter freisetzung, die einen opioid agonist und antagonist enthalten
AU776904B2 (en) 2000-02-08 2004-09-23 Euro-Celtique S.A. Controlled-release compositions containing opioid agonist and antagonist
SE0001151D0 (sv) * 2000-03-31 2000-03-31 Amarin Dev Ab Method for producing a controlled-release composition
US20040156872A1 (en) * 2000-05-18 2004-08-12 Elan Pharma International Ltd. Novel nimesulide compositions
US7198795B2 (en) * 2000-09-21 2007-04-03 Elan Pharma International Ltd. In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
US7276249B2 (en) * 2002-05-24 2007-10-02 Elan Pharma International, Ltd. Nanoparticulate fibrate formulations
KR100960200B1 (ko) * 2000-10-30 2010-05-27 유로-셀티크 소시에떼 아노뉨 서방성 하이드로코돈 제형
US20020106408A1 (en) * 2000-12-01 2002-08-08 Johnatan Bacon Prolamin-based sustained-release compositions and delayed-onset compositions
US20110104214A1 (en) 2004-04-15 2011-05-05 Purdue Pharma L.P. Once-a-day oxycodone formulations
UA81224C2 (uk) 2001-05-02 2007-12-25 Euro Celtic S A Дозована форма оксикодону та її застосування
DE60238756D1 (de) 2001-05-11 2011-02-10 Endo Pharmaceuticals Inc Opioid enthaltende arzneiform gegen missbrauch
WO2003007802A2 (en) * 2001-07-18 2003-01-30 Euro-Celtique, S.A. Pharmaceutical combinations of oxycodone and naloxone
JP4504013B2 (ja) 2001-08-06 2010-07-14 ユーロ−セルティーク エス．エイ． 放出可能な及び封鎖されたアンタゴニストを有するオピオイドアゴニスト製剤
AU2002324624A1 (en) * 2001-08-06 2003-02-24 Euro-Celtique S.A. Sequestered antagonist formulations
US20030044458A1 (en) * 2001-08-06 2003-03-06 Curtis Wright Oral dosage form comprising a therapeutic agent and an adverse-effect agent
US20030068375A1 (en) 2001-08-06 2003-04-10 Curtis Wright Pharmaceutical formulation containing gelling agent
PT1471887E (pt) 2002-02-04 2010-07-16 Elan Pharma Int Ltd ComposiãŽes de nanopartculas com lisozima como um estabilizador superficial
US7790905B2 (en) * 2002-02-15 2010-09-07 Mcneil-Ppc, Inc. Pharmaceutical propylene glycol solvate compositions
US20100311701A1 (en) * 2002-02-15 2010-12-09 Transform Pharmaceuticals, Inc Pharmaceutical Co-Crystal Compositions
US7927613B2 (en) * 2002-02-15 2011-04-19 University Of South Florida Pharmaceutical co-crystal compositions
US20090088443A1 (en) * 2002-02-15 2009-04-02 Julius Remenar Novel crystalline forms of conazoles and methods of making and using the same
JP4906233B2 (ja) 2002-03-01 2012-03-28 ユニバーシティー オブ サウス フロリダ 少なくとも１種の有効薬剤成分を含有する多構成要素固相
DE20308437U1 (de) * 2002-04-05 2003-11-13 Euroceltique S.A., Luxemburg/Luxembourg Matrix zur verzögerten, gleichbleibenden und unabhängigen Freisetzung von Wirkstoffen
US20070264348A1 (en) * 2002-05-24 2007-11-15 Elan Pharma International, Ltd. Nanoparticulate fibrate formulations
US6733578B2 (en) 2002-06-20 2004-05-11 Wm. Wrigley Jr. Company Plasticized prolamine compositions
MXPA05000232A (es) 2002-06-21 2005-06-17 Transform Pharmaceuticals Inc Composiciones farmaceuticas con disolucion mejorada.
US6858238B2 (en) * 2002-06-26 2005-02-22 Wm. Wrigley Jr. Company Chewing gum products including prolamine blends
US7399488B2 (en) 2002-07-05 2008-07-15 Collegium Pharmaceutical, Inc. Abuse-deterrent pharmaceutical compositions of opiods and other drugs
US8557291B2 (en) * 2002-07-05 2013-10-15 Collegium Pharmaceutical, Inc. Abuse-deterrent pharmaceutical compositions of opioids and other drugs
US8840928B2 (en) * 2002-07-05 2014-09-23 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
US10004729B2 (en) 2002-07-05 2018-06-26 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
WO2004006959A1 (en) * 2002-07-16 2004-01-22 Elan Pharma International, Ltd Liquid dosage compositions of stable nanoparticulate active agents
US20060052432A1 (en) * 2002-09-20 2006-03-09 Julius Remenar Pharmaceutical compositions with improved dissolution
CN1727471B (zh) * 2002-09-20 2013-03-06 中国科学院上海有机化学研究所 植物源性醇溶蛋白基质薄膜的用途
EP2422775A3 (en) 2002-09-20 2012-04-18 Alpharma, Inc. Sequestering subunit and related compositions and methods
AU2003284942A1 (en) * 2002-10-30 2004-06-07 Pharmacia Corporation Oral extended release tablets and methods of making and using the same
US20040086595A1 (en) * 2002-10-31 2004-05-06 Jingping Liu Plasticized prolamine compositions
AU2003295846A1 (en) * 2002-11-26 2004-06-18 Transform Pharmaceuticals, Inc. Pharmaceutical formulations of celcoxib
US20060099256A1 (en) * 2002-11-27 2006-05-11 Price James C Microspheres and related processes and pharmaceutical compositions
ATE482695T1 (de) 2002-12-13 2010-10-15 Durect Corp Orale darreichungsform mit flüssigen hochviskosen trägersystemen
EP2339328A3 (en) 2002-12-30 2011-07-13 Transform Pharmaceuticals, Inc. Pharmaceutical co-crystal compositions of celecoxib
US8183290B2 (en) 2002-12-30 2012-05-22 Mcneil-Ppc, Inc. Pharmaceutically acceptable propylene glycol solvate of naproxen
US20040202717A1 (en) 2003-04-08 2004-10-14 Mehta Atul M. Abuse-resistant oral dosage forms and method of use thereof
MY135852A (en) 2003-04-21 2008-07-31 Euro Celtique Sa Pharmaceutical products
CA2519556C (en) * 2003-04-21 2011-01-18 Benjamin Oshlack Tamper resistant dosage form comprising co-extruded, adverse agent particles and process of making same
KR100473422B1 (ko) * 2003-06-12 2005-03-14 박원봉 렉틴 함유 천연물의 장용성 코팅용 조성물
KR100511086B1 (ko) * 2003-09-17 2005-08-30 삼성정밀화학 주식회사 장용성의 수계 분산 히드록시프로필 메틸셀룰로오스프탈레이트 나노입자의 제조방법
PL1663229T3 (pl) 2003-09-25 2010-09-30 Euro Celtique Sa Farmaceutyczne kombinacje hydrokodonu i naltreksonu
US20050069590A1 (en) * 2003-09-30 2005-03-31 Buehler Gail K. Stable suspensions for medicinal dosages
EP1691892B1 (en) * 2003-12-09 2007-02-28 Euro-Celtique S.A. Tamper resistant co-extruded dosage form containing an active agent and an adverse agent and process of making same
US8883204B2 (en) * 2003-12-09 2014-11-11 Purdue Pharma L.P. Tamper resistant co-extruded dosage form containing an active agent and an adverse agent and process of making same
CA2548917C (en) 2003-12-11 2014-09-23 Sepracor Inc. Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
TWI483944B (zh) * 2004-03-30 2015-05-11 Euro Celtique Sa 含有小於２５ｐｐｍ１４-羥可待因酮之羥可酮鹽酸鹽組成物、醫藥劑型、延遲釋出口服劑型及醫藥上可以接受的包裝
CN1938004B (zh) * 2004-03-30 2011-12-21 欧洲凯尔特公司 包含吸附剂和不利剂的抗篡改剂型
EP1604666A1 (en) 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
EP1604667A1 (en) 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the restless leg syndrome
CA2569958C (en) 2004-06-12 2016-03-22 Jane C. Hirsh Abuse-deterrent drug formulations
US20100301254A1 (en) * 2004-06-23 2010-12-02 University Of Maine System Board Of Trustees Barrier compositions and articles produced with the compositions
US7737200B2 (en) * 2004-06-23 2010-06-15 University Of Maine System Board Of Trustees Barrier compositions and articles produced with the compositions
AU2005282784B2 (en) * 2004-09-01 2008-06-19 Euro-Celtique S.A. Opioid dosage forms having dose proportional steady state Cave and AUC and less than dose proportional single dose Cmax
EP1771160A2 (en) * 2005-01-28 2007-04-11 Euroceltique S.A. Alcohol resistant dosage forms
US20060188611A1 (en) * 2005-02-18 2006-08-24 Emine Unlu Edible pet chew
EP1695700A1 (en) * 2005-02-28 2006-08-30 Euro-Celtique S.A. Dosage form containing oxycodone and naloxone
EP1702558A1 (en) 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
EP1959966B1 (en) * 2005-11-28 2020-06-03 Marinus Pharmaceuticals, Inc. Ganaxolone formulations and methods for the making and use thereof
EP1981560B1 (en) * 2006-01-05 2010-09-08 Med Institute, Inc. Zein coated medical device
EP1813276A1 (en) * 2006-01-27 2007-08-01 Euro-Celtique S.A. Tamper resistant dosage forms
SI2484346T1 (sl) 2006-06-19 2017-05-31 Alpharma Pharmaceuticals Llc Farmacevtski sestavki
SA07280459B1 (ar) 2006-08-25 2011-07-20 بيورديو فارما إل. بي. أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
JP2010510988A (ja) * 2006-11-28 2010-04-08 マリナス ファーマシューティカルズ ナノ粒子製剤とその製造方法およびその利用
GB0624880D0 (en) * 2006-12-14 2007-01-24 Johnson Matthey Plc Improved method for making analgesics
EP2200613B1 (en) 2007-09-21 2018-09-05 The Johns Hopkins University Phenazine derivatives and uses thereof
WO2009067431A2 (en) 2007-11-20 2009-05-28 Cook Incorporated Controlled drug delivery using a zein layer modified with levulinic acid
AU2008335809A1 (en) 2007-12-06 2009-06-18 Durect Corporation Methods useful for the treatment of pain, arthritic conditions, or inflammation associated with a chronic condition
US8623418B2 (en) 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
US8697098B2 (en) 2011-02-25 2014-04-15 South Dakota State University Polymer conjugated protein micelles
US9233110B2 (en) 2008-05-09 2016-01-12 Omathanu P. Perumal Protein nanocarriers for topical delivery
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
PT2405915T (pt) 2009-03-10 2019-01-29 Euro Celtique Sa Composições farmacêuticas de libertação imediata compreendendo oxicodona e naloxona
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
PE20181177A1 (es) 2010-12-22 2018-07-20 Purdue Pharma Lp Formas de dosis de liberacion controlada encerradas resistentes a manipulaciones indebidas
CN103327969A (zh) 2010-12-23 2013-09-25 普渡制药公司 抗篡改固体口服剂型
CN103945830B (zh) * 2011-02-25 2017-06-06 南达科他州立大学 缀合蛋白的聚合物胶束
AU2012280966B2 (en) 2011-07-14 2017-03-16 Poet Research, Inc. Water-based prolamin compositions, methods of making water-based prolamin compositions, and applications thereof
EP2625966A1 (en) 2012-02-13 2013-08-14 Bionanoplus, S.L. Nanoparticles comprising a vegetable hydrophobic protein and a water miscible non-volatile organic solvent and uses thereof
CA3120681C (en) 2012-04-17 2024-05-28 Purdue Pharma L.P. Systems and methods for treating an opioid-induced adverse pharmacodynamic response
TWI588147B (zh) 2012-07-16 2017-06-21 羅德科技公司 改良之類鴉片合成方法
SG11201407988UA (en) 2012-07-16 2015-01-29 Rhodes Technologies Process for improved opioid synthesis
EA201500742A1 (ru) 2013-02-05 2015-12-30 Пердью Фарма Л.П. Защищенные от нецелевого использования фармацевтические композиции
US9273227B2 (en) 2013-03-06 2016-03-01 Poet Research, Inc. Waterborne aqueous-alcohol soluble protein compositions, applications, and methods
US10751287B2 (en) 2013-03-15 2020-08-25 Purdue Pharma L.P. Tamper resistant pharmaceutical formulations
TW201521769A (zh) 2013-03-15 2015-06-16 Durect Corp 具有流變改質劑以減少溶解變異性之組成物
NZ716267A (en) 2013-07-23 2017-05-26 Euro Celtique Sa A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation
BR112016002079A2 (pt) 2013-08-02 2017-09-05 Johnson Matthey Plc Processo para preparação de um aditivo ácido de oximorfona, solução aquosa de aditivo ácido de oximorfona, aditivo ácido de oximorfona sólido, e, alcaloide de oximorfona sólido
CA2937007C (en) 2014-01-15 2018-11-06 Rhodes Technologies Process for improved oxymorphone synthesis
WO2015107471A1 (en) 2014-01-15 2015-07-23 Rhodes Technologies Process for improved oxycodone synthesis
US9062063B1 (en) 2014-03-21 2015-06-23 Johnson Matthey Public Limited Company Forms of oxymorphone hydrochloride
US9849124B2 (en) 2014-10-17 2017-12-26 Purdue Pharma L.P. Systems and methods for treating an opioid-induced adverse pharmacodynamic response
CA2936746C (en) 2014-10-31 2017-06-27 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US9918979B2 (en) 2015-01-29 2018-03-20 Johnson Matthey Public Limited Company Process of preparing low ABUK oxymorphone hydrochloride
CA2975217C (en) 2015-02-13 2023-08-15 Mars, Incorporated Pet food feeding system
ES2925951T3 (es) 2015-07-22 2022-10-20 John Hsu Composición que comprende un agente terapéutico y un estimulante respiratorio y métodos para su uso
WO2017222575A1 (en) 2016-06-23 2017-12-28 Collegium Pharmaceutical, Inc. Process of making more stable abuse-deterrent oral formulations
GB201715660D0 (en) 2017-09-27 2017-11-08 Mars Inc Jaw assembly
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder
US20230143910A1 (en) * 2020-04-16 2023-05-11 Akorn Technology, Inc. Edible films and coatings employing water soluble corn prolamin and other functional ingredients
WO2021249621A1 (en) 2020-06-09 2021-12-16 Traceless Materials Gmbh Process for producing water-resistant films from corn gluten meal
CN112245409B (zh) * 2020-10-23 2022-03-15 安徽大学 一种植物蛋白-熊去氧胆酸缓释纳米粒复合微囊及其制备方法
CN112790370B (zh) * 2020-12-18 2023-07-28 上海交通大学 一种植物蛋白面团的制备方法
LU500976B1 (en) 2021-12-09 2023-06-09 Traceless Mat Gmbh Process for producing a thermoplastic material for use as a powder or granulate for further processing such as injection moulding or coating
LU500975B1 (en) 2021-12-09 2023-06-09 Traceless Mat Gmbh Process for producing a thermoplastic material for use as a film or as a flexible coating
CN115012227B (zh) * 2022-07-14 2024-03-26 江南大学 一种利用生物大分子制备疏水纺织品的方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2272488A (en) * 1942-02-10 Process fok the production of zein
GB516295A (en) * 1937-08-18 1939-12-29 Corn Prod Refining Co Improvements in and relating to the precipitation of zein
US2377237A (en) * 1940-08-03 1945-05-29 Corn Prod Refining Co Zein dispersions and processes of making same
US2676169A (en) * 1951-09-26 1954-04-20 Corn Prod Refining Co Method of treating zein
US2791509A (en) * 1954-06-24 1957-05-07 Horace B Cosler Method of producing zein-coated confectionery
US2772488A (en) * 1955-07-20 1956-12-04 Meltzer Jack Shoe having covered insole body and nailed-on heel
US3092553A (en) * 1959-01-30 1963-06-04 Jr Carl E Fisher Pharmaceutical preparations and method and apparatus for making same
DE1228757B (de) * 1962-06-28 1966-11-17 Haessle Ab Verfahren zur Herstellung eines in Wasser und Magensaft rasch zerfallenden UEberzuges auf festen Arzneiformen
US3370054A (en) * 1965-03-05 1968-02-20 Interchem Corp Zein prepared by strong alkali hydrolysis of aqueous alcoholic zein solutions and subsequent acid precipitation of the alkali
US3365365A (en) * 1965-08-09 1968-01-23 Hoffmann La Roche Repeat action pharmaceutical compositions in the form of discrete beadlets
FR2624351B1 (fr) * 1987-12-15 1991-11-22 Rhone Poulenc Sante Compositions degradables par voie enzymatique utilisables pour l'enrobage d'additifs alimentaires destines aux ruminants
MX170727B (es) * 1988-09-19 1993-09-09 Enzytech Inc Microparticulas de proteina hidrofibicas y preparacion de la misma
US4931295A (en) * 1988-12-02 1990-06-05 Wm. Wrigley Jr. Company Chewing gum containing high-potency sweetener particles with modified zein coating
CA1339632C (en) * 1989-02-15 1998-01-20 Robert A. Payne Method of producing an aqueous zein solution
WO1991006227A1 (en) * 1989-11-06 1991-05-16 Opta Food Ingredients, Inc. Protein-based edible coatings
DE69025334T2 (de) * 1989-11-06 1996-08-01 Alkermes Inc Herstellungsverfahren für proteinmikrosphären

Also Published As

Publication number Publication date
ATE172224T1 (de) 1998-10-15
ZA935869B (en) 1994-03-09
EP0585688A3 (pt) 1994-08-03
NO932867D0 (no) 1993-08-12
CA2103635A1 (en) 1994-02-14
IL106647A0 (en) 1993-12-08
US5324351A (en) 1994-06-28
MX9304900A (es) 1994-06-30
KR940005265A (ko) 1994-03-21
CN1086144A (zh) 1994-05-04
JPH06172398A (ja) 1994-06-21
AU4462193A (en) 1994-02-17
DE69321538D1 (de) 1998-11-19
PL300087A1 (en) 1994-04-18
EP0585688A2 (en) 1994-03-09
US5356467A (en) 1994-10-18
EP0585688B1 (en) 1998-10-14
DE69321538T2 (de) 1999-05-06

Similar Documents

Publication Publication Date Title
NO932867L (no) Vandige dispersjoner av zein og faste preparater med regulert frigjoerelse og med belegg avledet fra dispersjonene
ATE154822T1 (de) Präparate von fettlöslichen substanzen
NL193971B (nl) Perfusaat voor het conserveren van organen. Waterige samenstelling voor het conserveren en bewaren van organen.
WO1998056901A3 (en) Live attenuated vaccines
UA26890C2 (uk) Піримідиhові похідhі, що мають гербіцидhу активhість, спосіб їх отримаhhя, гербіцидhа композиція і спосіб зhищеhhя бур'яhів
NO883073D0 (no) 3-desmetyl-mevalonsyrederivater, fremgangsmaate til deres fremstilling samt deres anvendelse som mellomprodukter.
BR9203106A (pt) Composicao alimentar,utilizacao e composicao parenterica
IL98378A0 (en) Substituted phthalides and heterocyclic phthalides,their preparation and their use as herbicides
DK1409544T3 (da) Humane DR4-antistoffer og anvendelser deraf
IL146448A0 (en) Dr4 antibodies and uses thereof
MX9604434A (es) Productos farmaceuticos y medicamentos para la prevencion y el tratamiento de disfunciones endoteliales.
NL184895C (nl) Pyrido(3,4-f)-indoolderivaten met cytostatische eigenschappen, werkwijze voor het bereiden daarvan alsmede farmaceutische preparaten die dergelijke verbindingen bevatten.
DK23289D0 (da) Disubstituerede pyridinderivater, fremgangsmaade og mellemprodukter til deres fremstilling samt deres anvendelse
JPS5533497A (en) Silaasubstituted 1*44dihydropyridine derivative
IL141325A0 (en) Tan-1057 derivatives
ATE151768T1 (de) 5-(3-isoxazolyl)pyridin-3-carbonsäure-derivate verwendbar als herbizide
NO905347D0 (no) Tablett med kontrollert frigivelse av smaksingredienser, samt fremgangsmaate for fremstilling av tabletten.
IL99471A0 (en) Pharmaceutical compositions containing pyridylmethylsulphinyl-1h-benzimidazole derivatives as active ingredient therein
DK631588A (da) Transformerede maelkesyrebakterier, deres fremstilling, isolering og anvendelse samt fremgangsmaade til isolering af funktionelle gensegmenter.
MX9701764A (es) Derivados de imidoacidos.
HUT64072A (en) Herbicidal and plant growth regulating compositions, process for producintg glycolaldehyde and lactic and derivatives used as active ingredient and process for using the compositions
BG104452A (en) New derivatives of the methylenebisphosphonic acid
ATE102247T1 (de) Gamma-glutamylcysteintransferase, verfahren zu deren herstellung und deren verwendung.
IT1239273B (it) Procedimento di preparazione di aromi naturali al tartufo e prodotti ottenuti.
NZ268476A (en) 14-substituted marcfortines, preparation and pharmaceutical compositions thereof